Next Science Limited (ASX:NXS)

Judith Mitchell
Market Cap (AUD): 169.68M
Sector: Health Care
Last Trade (AUD): 0.79 +0 (+0%)
Tab Bar

1. About

Next Science Limited (ASX:NXS) is a medical technology company focused on the development and ongoing commercialisation of its proprietary Xbio technology designed to reduce the impact of biofilm-based infections in human health. 

Xbio is a unique, non-toxic technology with proven efficacy in eradicating both biofilm based and free-floating bacteria. 

Next Science owns the patent protected intellectual property relating to its Xbio technology.

The Company was established in 2012 and is headquartered in Sydney, Australia, with a research and development centre in Florida, USA.

2. Business model

3. Strategy

4. Markets

5. Competition

6. History

7. Team

8. Financials

9. Risk